The Patent Finder
US

Use of Botulinum Toxin for the Treatment of Cerebrovascular Disease, Renovascular and Retinovascular Circulatory Beds

US 9,393,291 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Botulinum Toxin Research Associates, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Collateral for a security interest recorded Feb 7, 2025 (Hayfin Services LLP).

Term ends Dec 16, 2033 · High confidence

Filed Apr 12, 2013 as application 13/862,206 · Granted Jul 19, 2016
Base term plus 248 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2013 2033
Clock starts
Apr 12, 2013
Term ends
Dec 16, 2033
Granted
Jul 19, 2016
base term patent term adjustment fee events Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
248
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 248 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 12, 2013, when this application, 13/862,206, was filedApr 12, 2033High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+248 days, USPTO patent term adjustment recordDec 16, 2033High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderDec 16, 2033High confidence

This family

US 9,393,291this patent
Dec 2033
Dec 2033
US 10,857,215In force
Apr 2033
Apr 2033
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Mar 24, 2016
Reel 38249, frame 697
Borodic, Gary e, DR; Acquadro, Martin a, DRBotulinum Toxin Research Associates, Inc.Assignment of Assignor's Interest
Jun 3, 2016
Reel 38870, frame 160
Botulinum Toxin Research Associates, Inc.Revance Therapeutics, Inc.Assignment of Assignor's Interest
Mar 18, 2022
Reel 59437, frame 654
Revance Therapeutics, Inc.Athyrium Buffalo LPSecurity Interest
Feb 7, 2025
Reel 70153, frame 630
Athyrium Buffalo LPRevance Therapeutics, Inc.Release of Security Interest
Feb 7, 2025
Reel 70153, frame 663
Revance Therapeutics, Inc.; Crown Laboratories, Inc.Hayfin Services LLP, as Administrative AgentSecurity Interest
Feb 7, 2025
Reel 70153, frame 736
Revance Therapeutics, Inc.; Bellus Medical, LLC; Crown Laboratories, Inc.Hayfin Services LLP, as Administrative AgentSecurity Interest
Feb 17, 2025
Reel 70239, frame 739
Revance Therapeutics, Inc.Jpmorgan Chase Bank, N.a.Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited